vs

Side-by-side financial comparison of Amphenol (APH) and Emerson Electric (EMR). Click either name above to swap in a different company.

Amphenol is the larger business by last-quarter revenue ($6.4B vs $4.3B, roughly 1.5× Emerson Electric). Amphenol runs the higher net margin — 18.6% vs 13.9%, a 4.6% gap on every dollar of revenue. On growth, Amphenol posted the faster year-over-year revenue change (49.1% vs 4.1%). Amphenol produced more free cash flow last quarter ($1.5B vs $602.0M). Over the past eight quarters, Amphenol's revenue compounded faster (40.6% CAGR vs -0.3%).

Amphenol Corporation is an American producer of electronic and fiber optic connectors, cable and interconnect systems such as coaxial cables. Amphenol is a portmanteau from the corporation's original name, American Phenolic Corp.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

APH vs EMR — Head-to-Head

Bigger by revenue
APH
APH
1.5× larger
APH
$6.4B
$4.3B
EMR
Growing faster (revenue YoY)
APH
APH
+45.0% gap
APH
49.1%
4.1%
EMR
Higher net margin
APH
APH
4.6% more per $
APH
18.6%
13.9%
EMR
More free cash flow
APH
APH
$866.5M more FCF
APH
$1.5B
$602.0M
EMR
Faster 2-yr revenue CAGR
APH
APH
Annualised
APH
40.6%
-0.3%
EMR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
APH
APH
EMR
EMR
Revenue
$6.4B
$4.3B
Net Profit
$1.2B
$605.0M
Gross Margin
38.2%
53.2%
Operating Margin
26.8%
17.8%
Net Margin
18.6%
13.9%
Revenue YoY
49.1%
4.1%
Net Profit YoY
60.2%
3.4%
EPS (diluted)
$0.93
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
APH
APH
EMR
EMR
Q4 25
$6.4B
$4.3B
Q3 25
$6.2B
$4.9B
Q2 25
$5.7B
$4.6B
Q1 25
$4.8B
$4.4B
Q4 24
$4.3B
$4.2B
Q3 24
$4.0B
$4.6B
Q2 24
$3.6B
$4.4B
Q1 24
$3.3B
$4.4B
Net Profit
APH
APH
EMR
EMR
Q4 25
$1.2B
$605.0M
Q3 25
$1.2B
$637.0M
Q2 25
$1.1B
$586.0M
Q1 25
$737.8M
$485.0M
Q4 24
$746.1M
$585.0M
Q3 24
$604.4M
$996.0M
Q2 24
$524.8M
$329.0M
Q1 24
$548.7M
$501.0M
Gross Margin
APH
APH
EMR
EMR
Q4 25
38.2%
53.2%
Q3 25
38.1%
51.9%
Q2 25
36.3%
52.6%
Q1 25
34.2%
53.5%
Q4 24
34.3%
53.5%
Q3 24
33.6%
51.3%
Q2 24
33.6%
52.8%
Q1 24
33.4%
52.2%
Operating Margin
APH
APH
EMR
EMR
Q4 25
26.8%
17.8%
Q3 25
27.5%
16.4%
Q2 25
25.1%
16.1%
Q1 25
21.3%
14.2%
Q4 24
22.1%
18.6%
Q3 24
20.3%
14.7%
Q2 24
19.4%
10.4%
Q1 24
21.0%
16.2%
Net Margin
APH
APH
EMR
EMR
Q4 25
18.6%
13.9%
Q3 25
20.1%
13.1%
Q2 25
19.3%
12.9%
Q1 25
15.3%
10.9%
Q4 24
17.3%
14.0%
Q3 24
15.0%
21.6%
Q2 24
14.5%
7.5%
Q1 24
16.9%
11.4%
EPS (diluted)
APH
APH
EMR
EMR
Q4 25
$0.93
$1.07
Q3 25
$0.97
$1.12
Q2 25
$0.86
$1.04
Q1 25
$0.58
$0.86
Q4 24
$0.16
$1.02
Q3 24
$0.48
$1.74
Q2 24
$0.41
$0.57
Q1 24
$0.87
$0.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
APH
APH
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$11.4B
Total DebtLower is stronger
$14.6B
$7.6B
Stockholders' EquityBook value
$13.4B
$20.3B
Total Assets
$36.2B
$41.9B
Debt / EquityLower = less leverage
1.09×
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
APH
APH
EMR
EMR
Q4 25
$11.4B
Q3 25
$3.9B
Q2 25
$3.2B
Q1 25
$1.7B
Q4 24
$3.3B
Q3 24
$1.6B
Q2 24
$1.3B
Q1 24
$2.0B
Total Debt
APH
APH
EMR
EMR
Q4 25
$14.6B
$7.6B
Q3 25
$7.1B
$8.9B
Q2 25
$7.1B
$8.3B
Q1 25
$6.8B
$8.2B
Q4 24
$6.5B
$6.6B
Q3 24
$5.1B
$7.7B
Q2 24
$5.0B
$7.1B
Q1 24
$3.6B
$7.6B
Stockholders' Equity
APH
APH
EMR
EMR
Q4 25
$13.4B
$20.3B
Q3 25
$12.5B
$20.3B
Q2 25
$11.5B
$19.9B
Q1 25
$10.3B
$19.2B
Q4 24
$9.8B
$20.5B
Q3 24
$9.5B
$21.6B
Q2 24
$9.0B
$20.8B
Q1 24
$8.7B
$20.9B
Total Assets
APH
APH
EMR
EMR
Q4 25
$36.2B
$41.9B
Q3 25
$27.1B
$42.0B
Q2 25
$25.7B
$42.5B
Q1 25
$22.9B
$42.0B
Q4 24
$21.4B
$42.6B
Q3 24
$19.6B
$44.2B
Q2 24
$18.6B
$45.6B
Q1 24
$16.7B
$46.4B
Debt / Equity
APH
APH
EMR
EMR
Q4 25
1.09×
0.37×
Q3 25
0.57×
0.44×
Q2 25
0.62×
0.42×
Q1 25
0.66×
0.42×
Q4 24
0.66×
0.32×
Q3 24
0.54×
0.36×
Q2 24
0.56×
0.34×
Q1 24
0.41×
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
APH
APH
EMR
EMR
Operating Cash FlowLast quarter
$1.7B
$699.0M
Free Cash FlowOCF − Capex
$1.5B
$602.0M
FCF MarginFCF / Revenue
22.8%
13.9%
Capex IntensityCapex / Revenue
3.9%
2.2%
Cash ConversionOCF / Net Profit
1.44×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$4.4B
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
APH
APH
EMR
EMR
Q4 25
$1.7B
$699.0M
Q3 25
$1.5B
$3.1B
Q2 25
$1.4B
$1.1B
Q1 25
$764.9M
$241.0M
Q4 24
$847.1M
$777.0M
Q3 24
$704.0M
$3.3B
Q2 24
$664.1M
$1.1B
Q1 24
$599.5M
$743.0M
Free Cash Flow
APH
APH
EMR
EMR
Q4 25
$1.5B
$602.0M
Q3 25
$1.2B
$2.7B
Q2 25
$1.1B
$977.0M
Q1 25
$576.3M
$154.0M
Q4 24
$647.3M
$694.0M
Q3 24
$474.0M
$2.9B
Q2 24
$522.8M
$998.0M
Q1 24
$505.2M
$661.0M
FCF Margin
APH
APH
EMR
EMR
Q4 25
22.8%
13.9%
Q3 25
19.6%
54.9%
Q2 25
19.8%
21.5%
Q1 25
12.0%
3.5%
Q4 24
15.0%
16.6%
Q3 24
11.7%
63.1%
Q2 24
14.5%
22.8%
Q1 24
15.5%
15.1%
Capex Intensity
APH
APH
EMR
EMR
Q4 25
3.9%
2.2%
Q3 25
4.2%
8.9%
Q2 25
5.3%
2.0%
Q1 25
3.9%
2.0%
Q4 24
4.6%
2.0%
Q3 24
5.7%
9.1%
Q2 24
3.9%
2.1%
Q1 24
2.9%
1.9%
Cash Conversion
APH
APH
EMR
EMR
Q4 25
1.44×
1.16×
Q3 25
1.18×
4.86×
Q2 25
1.30×
1.83×
Q1 25
1.04×
0.50×
Q4 24
1.14×
1.33×
Q3 24
1.16×
3.35×
Q2 24
1.27×
3.31×
Q1 24
1.09×
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

APH
APH

Communications Solutions Segment$3.5B54%
Harsh Environment Solutions Segment$1.7B26%
Sales Channel Through Intermediary$1.4B21%

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons